Skip to main content
. 2023 Jul 25;23:539. doi: 10.1186/s12888-023-05013-2

Table 1.

Comparison of participants’ demographic characteristics group-wise and overall

Variables Category Overall Groups
Characteristics Experimental Control χ2/t p
N Allocated 126 63(50.0%) 63(50.0%)
N Dropout 46 23(50.0%) 23(50.0%)
N Final 80 40(50.0%) 40(50.0%)
Age 126 31.87(8.35) 31.93(8.53) -.042 .846
Monthly Income M(SD) 126 16,857.14(8153.48) 15,476.19(6951.11) 1.023 .380
Gender Male (n%) 52 25(39.7%) 27(42.9%) .131 .717
Female (n%) 74 38(60.3%) 36(57.1%)
Education  < Matric.(n%) 72 35(55.6%) 37(58.7%) .376 .829
Matric. (n%) 33 18(28.6%) 15(23.8%)
 > Matric. (n%) 21 10(15.9%) 11(17.5%)
Birth Order First (n%) 26 14(22.2%) 12(19.0%) 1.004 .605
Other (n%) 80 41(65.1%) 39(61.9%)
Last (n%) 20 8(12.7%) 12(19.0%)
Marital Status Married (n%) 107 52(82.5%) 55(87.3%) .558 .455
Single (n%) 19 11(17.5%) 8(12.7%)
Family System Nuclear (n%) 77 41(65.1%) 36(57.1%) .835 .361
Joint (n%) 49 22(34.9%) 27(42.9%)
Reason of HIV/AIDS Don’t Know (n%) 81 38(60.3%) 43(68.3%) 1.052 .591
Used syringe (n%) 37 20(31.7%) 17(27.0%)
Blood Transfusion (n%) 8 5(7.9%) 3(4.8%)
Duration of HIV/AIDS diagnosis 1 Month to 1.5 years (n%) 83 41(65.1%) 42(66.7%) .155 .925
 < 2.5 year (n%) 36 18(28.6%) 18(28.6%)
 > 3.5 years (n%) 7 4(6.3%) 3(4.8%)
Duration of HIV/AIDS medication 1 Month to 1.5 years (n%) 84 42(66.7%) 42(66.7%) .171 .918
 < 2.5 year (n%) 35 17(27.0%) 18(28.6%)
 > 3.5 years (n%) 7 4(6.3%) 3(4.8%)
Age at diagnosis 126 30.59(8.11) 30.67(8.47) -.054 .766
A family member died due to HIV/AIDS Yes (n%) 117 57(90.5%) 60(95.2%) 1.077 .299
No (n%) 9 6(9.5%) 3(4.8%)
Any other family member diagnosed with HIV/AIDS Yes (n%) 79 41(65.1%) 38(60.3%) .305 .581
No (n%) 47 22(34.9%) 25(39.7%)
Information about HIV/AIDS Don’t Know (n%) 106 51(81.0%) 55(87.3%) .951 .329
Know (n%) 20 12(19.0%) 8(12.7%)
Medication dose Irregularity No (n%) 81 39(61.9%) 42(66.7%) .311 .577
Yes (n%) 45 24(38.1%) 21(33.3%)